References
Geissler K (1996) Current status of clinical development of interleukin-10. Curr Opin Hematol 3:203–208
Geissler K, Hinterberger W, Bettelheim P, Haas O, Lechner K (1988) Colony growth characteristics in chronic myelomonocytic leukemia. Leuk Res 12:373–377
Geissler K, Ohler L, Födinger M, Virgolini I, Leimer M, Kabrna E, Kollars M, Skoupy S, Bohle B, Rogy M, Lechner K (1996) Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells. J Exp Med 184:1377–1384
de Waal MR, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209–1220
Schreiber S, Fedorak RN, Nielsen OH, Wild G, Williams CN, Nikolaus S, Jacyna M, Lashner BA, Gangl A, Rutgeerts P, Isaacs K, van Deventer SJ, Koningsberger JC, Cohard M, LeBeaut A, Hanauer SB (2000) Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn’s disease. Crohn’s Disease IL-10 Cooperative Study Group. Gastroenterology 119:1461–1472
Keystone E, Wherry J, Grint P (1998) IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis. Rheum Dis Clin N Am 24:629–639
Asadullah K, Döcke WD, Ebeling M, Friedrich M, Belbe G, Audring H, Volk HD, Sterry W (1999) Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial. Arch Dermatol 135:187–192
Zuckerman SH, Ackerman SK, Douglas SD (1979) Long-term human peripheral blood monocyte cultures: establishment, metabolism and morphology of primary human monocyte-macrophage cell cultures. Immunology 38:401–411
Fenaux P, Jouet JP, Zandecki M, Lai JL, Simon M, Pollet JP, Bauters F (1987) Chronic and subacute myelomonocytic leukaemia in the adult: a report of 60 cases with special reference to prognostic factors. Br J Haematol 65:101–106
Yokozeki H, Takayama K, Ohki O, Satoh T, Umeda T, Katayama I, Nishioka K (1998) Comparative analysis of CD80 and CD86 on human Langerhans cells: expression and function. Arch Dermatol Res 290:547–552
Acknowledgments
This work was supported by AESCA Pharma Ges.m.b.H., Traiskirchen, Austria.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pöchlauer, S., Jäger, E., Jäger, U. et al. Recombinant human interleukin-10 in patients with chronic myelomonocytic leukemia. Ann Hematol 93, 1775–1776 (2014). https://doi.org/10.1007/s00277-014-2012-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-014-2012-5